Kobayashi Kako Submits Report on Drug Mix-Up, Could Face Administrative Penalty in 1st Half of February

To read the full story

• Sign In
• Subscribe

Related Article

• Kobayashi Kako Submits Biz Improvement Plan Over Fudged Drug Filings
  May 31, 2021

• Biz Improvement Order Issued to 3 Codevelopers over Kobayashi Kako’s Fudged Data
  May 24, 2021

• MHLW Revokes Approval for 12 Kobayashi Kako Products, Imposes Biz Improvement Order
  April 30, 2021

• Kobayashi Kako Starts Recalling Products Subject to Approval Revocation
  April 22, 2021

• Kobayashi Kako Chief Sorry for Fake Application Documents; Third-Party Report Reveals New Problems
  April 19, 2021

• MHLW to Revoke Approval of 12 Kobayashi Kako Products as Documents Fabricated
  April 19, 2021

• Kobayashi Kako’s Seima Factory Operations Still Halted Even after 60-Day Order Lifted
  April 12, 2021

• Kobayashi Kako to Invite Outsider to Take Over Top Post: Biz Improvement Plan
  March 11, 2021

• Meiji to Discontinue Sale of Kobayashi Kako Products after Biz Suspension
  February 26, 2021

• 4 APIs/9 Products Excluded from Kobayashi Kako Biz Suspension for Medical Needs
  February 24, 2021

• Kobayashi Kako Chief to Resign over Drug Mix-Up, Lousy Manufacturing and Cover-Ups
  February 10, 2021

• Kobayashi Kako Expelled from JGA over Drug Mix-Up
  February 10, 2021

• Kobayashi Kako Slapped with Record 116-Day Business Suspension
  February 9, 2021

• Regulators to Issue Biz Suspension Order to Kobayashi Kako on Feb. 9
  February 8, 2021

• Kobayashi Kako Might Face 116-Day Biz Suspension over Drug Mix-Up
  January 27, 2021

• Kobayashi Kako Notified of Record Biz Suspension of 110-Plus Days over Drug Mix-Up
  January 26, 2021

• Kobayashi Kako Expected to Face Administrative Penalty This Fiscal Year, Biz Suspension Likely
  January 12, 2021

• First Time FPMAJ’s Supply Coordination Scheme Invoked for 13 APIs Tied to Kobayashi Kako
  January 5, 2021

• Kobayashi Kako Adds 2 APIs to Class II Recall List, Meiji/Elmed Products
  December 28, 2020

• Kobayashi Kako Recalls 12 More APIs after On-Site Inspections
  December 25, 2020

• Results of On-Site Probe into Kobayashi Kako Due Out Early Next Year, MHLW Eyes Biz Suspension
  December 24, 2020

• 2nd Death Reported for Tainted Itraconazole User, Doctor Says Causal Link Unlikely
  December 18, 2020

• Kobayashi Kako Manually Managed Itraconazole Production; Hand-Written Record on Rilmazafone Mix-Up Found
  December 17, 2020

• Kobayashi Kako Temporary Halts Shipments of All Products after Tainted Itraconazole Issue
  December 15, 2020

• 1st Death Reported for Kobayashi Kako’s Tainted Itraconazole Product
  December 14, 2020

• Kobayashi Kako Recalls Trigger Shipment Control for Kaken's Itraconazole Product
  December 11, 2020

• Pharmacist Group Chief Appalled at Itraconazole Recalls; 84 Cases of Health Damages Reported
  December 10, 2020

• With Contaminated Itraconazole, Patients Might Have Taken Sleep Inducer at 10-20 Times Regular Dosage
  December 9, 2020

• Kobayashi Kako Launches Another Recall for Itraconazole, Class II This Time
  December 8, 2020

• Kobayashi Kako Recalls Itraconazole over Hypnotic Contamination; Side Effects Confirmed
  December 7, 2020